VELSIPITY Trademark

Trademark Overview

On Thursday, June 27, 2019, a trademark application was filed for VELSIPITY with the United States Patent and Trademark Office. The USPTO has given the VELSIPITY trademark a serial number of 88491734. The federal status of this trademark filing is REGISTERED as of Tuesday, March 5, 2024. This trademark is owned by Arena Pharmaceuticals, Inc.. The VELSIPITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, and autoimmune diseases
velsipity

General Information

Serial Number88491734
Word MarkVELSIPITY
Filing DateThursday, June 27, 2019
Status700 - REGISTERED
Status DateTuesday, March 5, 2024
Registration Number7322963
Registration DateTuesday, March 5, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 8, 2019
Primary Code005
First Use Anywhere DateFriday, August 5, 2022
First Use In Commerce DateFriday, August 5, 2022

Trademark Owner History

Party NameArena Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219
Party NameArena Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219
Party NameArena Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, March 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 5, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, January 30, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 29, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 29, 2024ASSIGNED TO LIE
Friday, May 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 8, 2023NON-FINAL ACTION E-MAILED
Monday, May 8, 2023SU - NON-FINAL ACTION - WRITTEN
Monday, May 8, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, May 1, 2023USE AMENDMENT FILED
Monday, May 1, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 9, 2022SOU EXTENSION 5 GRANTED
Monday, October 31, 2022SOU EXTENSION 5 FILED
Monday, November 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 31, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 16, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 16, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 2, 2022SOU EXTENSION 4 GRANTED
Thursday, June 2, 2022SOU EXTENSION 4 FILED
Thursday, June 2, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 27, 2022ASSIGNED TO EXAMINER
Tuesday, January 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 3 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 3 FILED
Tuesday, November 23, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 24, 2021SOU EXTENSION 2 GRANTED
Monday, May 24, 2021SOU EXTENSION 2 FILED
Monday, May 24, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020SOU EXTENSION 1 GRANTED
Monday, December 14, 2020SOU EXTENSION 1 FILED
Monday, December 14, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 18, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, March 18, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 18, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, March 18, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, September 23, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, September 23, 2019PRIORITY ACTION E-MAILED
Monday, September 23, 2019PRIORITY ACTION WRITTEN
Wednesday, September 18, 2019ASSIGNED TO EXAMINER
Tuesday, August 13, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, August 8, 2019ASSIGNED TO LIE
Thursday, August 1, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 1, 2019NEW APPLICATION ENTERED

Related Keywords

velsipity diseases disease crohn irritable bowel autoimmune syndrome tract disorders human